$222 Million is the total value of CARDEROCK CAPITAL MANAGEMENT INC's 72 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCLN | Priceline | $3,081,000 | -2.1% | 1,683 | 0.0% | 1.39% | -2.1% | |
| CTSH | Cognizant Tech | $1,334,000 | +9.3% | 18,387 | 0.0% | 0.60% | +9.3% | |
| JNJ | Johnson & Johnson | $934,000 | -1.8% | 7,186 | 0.0% | 0.42% | -1.9% | |
| TROW | TRPrice Assoc | $904,000 | +22.2% | 9,975 | 0.0% | 0.41% | +22.2% | |
| BMY | Bristol-Myers Squibb | $553,000 | +14.5% | 8,675 | 0.0% | 0.25% | +14.2% | |
| CLX | Clorox Co | $323,000 | -1.2% | 2,451 | 0.0% | 0.15% | -1.4% | |
| PAYX | Paychex | $300,000 | +5.3% | 5,000 | 0.0% | 0.14% | +4.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Apple Computer | 42 | Q3 2023 | 6.6% |
| MasterCard Worldwide | 42 | Q3 2023 | 4.7% |
| Accenture PLC Cl A | 42 | Q3 2023 | 3.5% |
| Thermo Fisher Scientific | 42 | Q3 2023 | 4.3% |
| Roper Technologies Inc | 42 | Q3 2023 | 3.5% |
| Danaher Corp | 42 | Q3 2023 | 3.2% |
| Amphenol Corp New Cl A | 42 | Q3 2023 | 2.9% |
| Idexx Labs | 42 | Q3 2023 | 3.3% |
| Intuit | 42 | Q3 2023 | 3.3% |
| Church & Dwight | 42 | Q3 2023 | 2.9% |
View CARDEROCK CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-23 |
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-25 |
| 13F-HR | 2023-04-19 |
| 13F-HR | 2023-01-20 |
| 13F-HR/A | 2022-11-04 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-21 |
| 13F-HR | 2022-04-28 |
View CARDEROCK CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.